MD HB1045

Restricts Maryland's Prescription Drug Monitoring Program from disclosing prescription data to federal law enforcement agencies when the data involves "sensitive health services information" that has been designated as "legally protected health care" by the Secretary of Health

Federal law enforcement can still obtain prescription monitoring data via subpoena for bona fide investigations, but only if the data has not been classified as legally protected health care by the Protected Health Care Commission

State and local law enforcement agencies remain able to access prescription monitoring data via subpoena without the new restriction

Designated as an emergency bill, requiring three-fifths approval in both chambers and taking effect immediately upon enactment

References the existing Protected Health Care Commission (§ 4-310), which identifies sensitive health services by diagnosis, procedural, medication, or related codes that could create substantial risk to patients or providers if disclosed